[Federal Register Volume 90, Number 102 (Thursday, May 29, 2025)]
[Notices]
[Pages 22704-22707]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-09699]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration

[A-570-184]


Hard Empty Capsules From the People's Republic of China: 
Preliminary Affirmative Determination of Sales at Less Than Fair Value, 
Postponement of Final Determination, and Extension of Provisional 
Measures

AGENCY: Enforcement and Compliance, International Trade Administration, 
Department of Commerce.

SUMMARY: The U.S. Department of Commerce (Commerce) preliminarily 
determines that hard empty capsules (capsules) from the People's 
Republic of China (China) are being, or are likely to be, sold in the 
United States at less than fair value (LTFV). The period of 
investigation (POI) is April 1, 2024, through September 30, 2024. 
Interested parties are invited to comment on this preliminary 
determination.

DATES: Applicable May 29, 2025.

FOR FURTHER INFORMATION CONTACT: Rebecca Janz or Jerry Xiao, AD/CVD 
Operations, Office II, Enforcement and Compliance, International Trade 
Administration, U.S. Department of Commerce, 1401 Constitution Avenue 
NW, Washington, DC 20230; telephone: (202) 482-2972 or (202) 482-2273, 
respectively.

SUPPLEMENTARY INFORMATION:

Background

    This preliminary determination is made in accordance with section 
733(b) of the Tariff Act of 1930, as amended (the Act). Commerce 
published the notice of initiation of this investigation on November 
20, 2024.\1\ On March 5, 2025, Commerce postponed the preliminary 
determination of this investigation until May 22, 2025.\2\ For a 
complete description of the events that followed the initiation of this 
investigation, see the Preliminary Decision Memorandum.\3\ A list of 
topics included in the Preliminary Decision Memorandum is included as 
Appendix

[[Page 22705]]

II to this notice. The Preliminary Decision Memorandum is a public 
document and is on file electronically via Enforcement and Compliance's 
Antidumping and Countervailing Duty Centralized Electronic Service 
System (ACCESS). ACCESS is available to registered users at https://access.trade.gov. In addition, a complete version of the Preliminary 
Decision Memorandum can be accessed directly at https://access.trade.gov/public/FRNoticesListLayout.aspx.
---------------------------------------------------------------------------

    \1\ See Hard Empty Capsules from Brazil, the People's Republic 
of China, India, and the Socialist Republic of Vietnam: Initiation 
of Less-Than-Fair-Value Investigations, 89 FR 91684 (November 20, 
2024) (Initiation Notice).
    \2\ See Hard Empty Capsules from Brazil, the People's Republic 
of China, India, and the Socialist Republic of Vietnam: Postponement 
of Preliminary Determinations in the Less-Than-Fair-Value 
Investigations, 90 FR 11257 (March 5, 2025).
    \3\ See Memorandum, ``Decision Memorandum for the Preliminary 
Affirmative Determination in the Less-Than-Fair-Value Investigation 
of Hard Empty Capsules from the People's Republic of China,'' dated 
concurrently with, and hereby adopted by, this notice (Preliminary 
Decision Memorandum).
---------------------------------------------------------------------------

Scope of the Investigation

    The merchandise covered by this investigation is capsules from 
China. For a complete description of the scope of this investigation, 
see Appendix I.

Scope Comments

    In accordance with the Preamble to Commerce's regulations,\4\ in 
the Initiation Notice, Commerce set aside a period of time for parties 
to raise issues regarding product coverage (i.e., scope).\5\ Certain 
interested parties commented on the scope of the investigation as it 
appeared in the Initiation Notice. For a summary of the product 
coverage comments and rebuttal responses submitted to the record for 
this investigation, and accompanying discussion and analysis of all 
comments timely received, see the Preliminary Scope Decision 
Memorandum.\6\ Commerce is not preliminarily modifying the scope 
language as it appeared in the Initiation Notice. See the scope in 
Appendix I to this notice. In the Preliminary Scope Decision 
Memorandum, Commerce established the deadline for parties to submit 
scope case and rebuttal briefs.\7\
---------------------------------------------------------------------------

    \4\ See Antidumping Duties; Countervailing Duties, Final Rule, 
62 FR 27296, 27323 (May 19, 1997) (Preamble).
    \5\ See Initiation Notice, 89 FR at 91685.
    \6\ See Memorandum, ``Less-Than-Fair-Value and Countervailing 
Duty Investigations of Hard Empty Capsules from Brazil, the People's 
Republic of China, India, and the Socialist Republic of Vietnam: 
Scope Comments Decision Memorandum for the Preliminary 
Determination,'' dated March 24, 2025 (Preliminary Scope Decision 
Memorandum).
    \7\ Id. at 10.
---------------------------------------------------------------------------

Methodology

    Commerce is conducting this investigation in accordance with 
section 731 of the Act. Commerce has calculated constructed export 
prices in accordance with section 772(b) of the Act. Because China is a 
non-market economy (NME), within the meaning of section 771(18) of the 
Act, Commerce has calculated normal value in accordance with section 
773(c) of the Act. Furthermore, pursuant to sections 776(a) and (b) of 
the Act, Commerce has preliminarily relied upon partial facts otherwise 
available, with adverse inferences, in determining the estimated 
weighted-average dumping margin for Shandong Healsee Capsule Ltd. 
(Shandong Healsee). For a full description of the methodology 
underlying Commerce's preliminary determination, see the Preliminary 
Decision Memorandum.

Combination Rates

    In the Initiation Notice,\8\ Commerce stated that it would 
calculate producer/exporter combination rates for the respondents that 
are eligible for a separate rate in this investigation. Policy Bulletin 
05.1 describes this practice.\9\
---------------------------------------------------------------------------

    \8\ See Initiation Notice, 89 FR at 91689.
    \9\ See Enforcement and Compliance's Policy Bulletin No. 05.1, 
regarding, ``Separate-Rates Practice and Application of Combination 
Rates in Antidumping Investigations involving Non-Market Economy 
Countries,'' (April 5, 2005) (Policy Bulletin 05.1), available on 
Commerce's website at https://enforcement.trade.gov/policy/bull05-1.pdf.
---------------------------------------------------------------------------

Separate Rate Companies and the China-Wide Entity

    We preliminarily granted a separate rate to certain respondents 
that we did not select for individual examination.\10\ In calculating 
the rate for non-individually examined separate rate respondents in an 
NME LTFV investigation, Commerce normally looks to section 735(c)(5)(A) 
of the Act, which pertains to the calculation of the all-others rate in 
a market economy LTFV investigation, for guidance. Pursuant to section 
735(c)(5)(A) of the Act, normally this rate shall be an amount equal to 
the weighted-average of the estimated weighted-average dumping margins 
established for those companies individually examined, excluding zero 
and de minimis estimated weighted-average dumping margins and any 
estimated weighted-average dumping margins based entirely under section 
776 of the Act.
---------------------------------------------------------------------------

    \10\ See the Preliminary Decision Memorandum for further 
discussion.
---------------------------------------------------------------------------

    In this investigation, Commerce preliminarily calculated individual 
estimated weighted-average dumping margins for Shandong Healsee and 
Shanxi JC Biological Technology Co., Ltd. (Shanxi JC) that are not 
zero, de minimis, or based entirely on facts otherwise available. Thus, 
the estimated weighted-average dumping margins calculated for Shandong 
Healsee and Shanxi JC are the basis on which we preliminarily 
determined the estimated weighted-average dumping margin for the non-
examined, separate rate companies in this investigation.\11\
---------------------------------------------------------------------------

    \11\ See Memorandum, ``Preliminary Calculation of the Dumping 
Margin for Respondents Not Selected for Individual Examination,'' 
dated concurrently with this notice.
---------------------------------------------------------------------------

    Furthermore, because we preliminarily do not find that the China-
wide entity failed to cooperate in this investigation, we also 
preliminarily assigned this same rate as the estimate weighted-average 
dumping margin for the China-wide entity.\12\
---------------------------------------------------------------------------

    \12\ See Preliminary Decision Memorandum for further discussion.
---------------------------------------------------------------------------

Preliminary Determination

    Commerce preliminarily determines that the following estimated 
weighted-average dumping margins exist:
---------------------------------------------------------------------------

    \13\ Hubei Kornnac Pharmaceutical Co., Ltd. (Hubei Kornnac) 
initially filed a separate rate application under the name ``Hubei 
Humanwell Pharmaceutical Excipients Co., Ltd.'' and subsequently 
notified Commerce that the company's name changed to Hubei Kornnac. 
We preliminarily determine it is appropriate to allow the name 
change. See Preliminary Decision Memorandum for further discussion.

----------------------------------------------------------------------------------------------------------------
                                                                    Estimated
                                                                weighted-average    Cash deposit rate  (adjusted
              Producer                        Exporter           dumping margin        for  subsidy offsets)
                                                                    (percent)                (percent)
----------------------------------------------------------------------------------------------------------------
Shandong Healsee Capsule Ltd........  Shandong Healsee                     172.24  Not Applicable.
                                       Capsule Ltd.
Shanxi JC Biological Technology Co.,  Shanxi JC Biological                   5.40  Not Applicable.
 Ltd.                                  Technology Co., Ltd.
Guizhou Guang De Li Pharmaceuticals   Guizhou Guang De Li                   88.82  Not Applicable.
 Co., Ltd.                             Pharmaceuticals Co.,
                                       Ltd.
Hebei Kangxin Plant Capsule Co., Ltd  Hebei Kangxin Plant                   88.82  Not Applicable.
                                       Capsule Co., Ltd.
Hubei Kornnac Pharmaceutical Co.,     Hubei Kornnac                         88.82  Not Applicable.
 Ltd.\13\.                             Pharmaceutical Co.,
                                       Ltd.
Jiangsu Lefan Capsule Co., Ltd......  Jiangsu Lefan Capsule                 88.82  Not Applicable.
                                       Co., Ltd.
Jiujiang Angtai Capsule Co., Ltd....  Jiujiang Angtai Capsule               88.82  Not Applicable.
                                       Co., Ltd.
Qingdao Yiqing Biotechnology Co.,     Qingdao Yiqing                        88.82  Not Applicable.
 Ltd.                                  Biotechnology Co., Ltd.
Shaanxi Genex Bio-Tech Co., Ltd.....  Shaanxi Genex Bio-Tech                88.82  Not Applicable.
                                       Co., Ltd.

[[Page 22706]]

 
Shanghai Guang De Li Capsule Co.,     Shanghai Guang De Li                  88.82  Not Applicable.
 Ltd.                                  Capsule Co., Ltd.
Shanxi Guangsheng Medicinal Capsule   Shanxi Guangsheng                     88.82  Not Applicable.
 Co., Ltd. A.K.A. Shanxi Guangsheng    Medicinal Capsule Co.,
 Capsule Co., Ltd.                     Ltd. A.K.A. Shanxi
                                       Guangsheng Capsule
                                       Co., Ltd.
Shaoxing Kangke Capsule Co., Ltd....  Shaoxing Kangke Capsule               88.82  Not Applicable.
                                       Co., Ltd.
Shaoxing Renhe Capsule Co., Ltd.....  Shaoxing Renhe Capsule                88.82  Not Applicable.
                                       Co., Ltd.
Xinchang County Hexin Capsule Co.,    Xinchang County Hexin                 88.82  Not Applicable.
 Ltd.                                  Capsule Co., Ltd.
Xinchang County No.6 Capsule Factory  Xinchang Paulo Import                 88.82  Not Applicable.
                                       And Export Co., Ltd.
Shaoxing Kangke Capsule Co., Ltd....  Xinchang Paulo Import                 88.82  Not Applicable.
                                       And Export Co., Ltd.
Zhejiang Huaguang Capsule Co., Ltd..  Xinchang Paulo Import                 88.82  Not Applicable.
                                       And Export Co., Ltd.
Shanxi Guangsheng Capsule Co., Ltd..  Xinchang Paulo Import                 88.82  Not Applicable.
                                       And Export Co., Ltd.
Zhejiang Pujiang Enerkang Capsule     Xinchang Paulo Import                 88.82  Not Applicable.
 Co., Ltd.                             And Export Co., Ltd.
Yantai Oriental Pharmacap Co., Ltd..  Yantai Oriental                       88.82  Not Applicable.
                                       Pharmacap Co., Ltd.
Ningbo Capsulcn Capsule Co., Ltd....  Zhejiang Capsulcn                     88.82  Not Applicable.
                                       Machinery Co., Ltd.
Shaoxing Zhongya Capsules Industry    Zhejiang Capsulcn                     88.82  Not Applicable.
 Co., Ltd.                             Machinery Co., Ltd.
Shandong Healsee Capsule Ltd........  Zhejiang Capsulcn                     88.82  Not Applicable.
                                       Machinery Co., Ltd.
Zhejiang Guangjuyuan Biotechnology    Zhejiang Capsulcn                     88.82  Not Applicable.
 Co., Ltd.                             Machinery Co., Ltd.
Zhejiang Huaguang Capsule Co., Ltd..  Zhejiang Capsulcn                     88.82  Not Applicable.
                                       Machinery Co., Ltd.
Zhejiang Huaguang Capsule Co., Ltd..  Zhejiang Huaguang                     88.82  Not Applicable.
                                       Capsule Co., Ltd.
Zhejiang Huili Capsules Co., Ltd....  Zhejiang Huili Capsules               88.82  Not Applicable.
                                       Co., Ltd.
Zhejiang Lujian Capsule Co., Ltd....  Zhejiang Lujian Capsule               88.82  Not Applicable.
                                       Co., Ltd.
----------------------------------------------------------------------------------------------------------------
China-Wide Entity............................................               88.82  Not Applicable.
----------------------------------------------------------------------------------------------------------------

Suspension of Liquidation

    In accordance with section 733(d)(2) of the Act, Commerce will 
direct U.S. Customs and Border Protection (CBP) to suspend liquidation 
of subject merchandise, as described in Appendix I, entered, or 
withdrawn from warehouse, for consumption on or after the date of 
publication of this notice in the Federal Register, as discussed below. 
Further, pursuant to section 733(d)(1)(B) of the Act and 19 CFR 
351.205(d), Commerce will instruct CBP to require a cash deposit equal 
to the weighted average amount by which normal value exceeds U.S. 
price, as indicated in the chart above, as follows: (1) for the 
producer/exporter combinations listed in the table above, the cash 
deposit rate is equal to the estimated weighted-average dumping margin 
listed for that combination in the table; (2) for all combinations of 
China producers/exporters of merchandise under consideration that have 
not established eligibility for their own separate rates, the cash 
deposit rate will be equal to the estimated weighted-average dumping 
margin established for the China-wide entity; and (3) for all third-
county exporters of merchandise under consideration not listed in the 
table above, the cash deposit rate is the cash deposit rate applicable 
to the China producer/exporter combination (or the China-wide entity) 
that supplied that third-country exporter.
    To determine the cash deposit rate, Commerce normally adjusts the 
estimated weighted-average dumping margin by the amount of domestic 
subsidy pass-through and export subsidies determined in a companion 
countervailing duty (CVD) proceeding when CVD provisional measures are 
in effect. However, Commerce has not made a preliminary affirmative 
determination for domestic subsidy pass-through or export subsidies; 
thus, Commerce has not offset the calculated estimated weighted-average 
dumping margins in this preliminary determination.
    These suspension of liquidation instructions will remain in effect 
until further notice.

Disclosure

    Commerce intends to disclose to interested parties the calculations 
performed in connection with this preliminary determination within five 
days of its public announcement or, if there is no public announcement, 
within five days of the date of publication of this notice in 
accordance with 19 CFR 351.224(b).
    Consistent with 19 CFR 351.224(e), Commerce will analyze and, if 
appropriate, correct any timely allegations of significant ministerial 
errors by amending the preliminary determination. However, consistent 
with 19 CFR 351.224(d), Commerce will not consider incomplete 
allegations that do not address the significance standard under 19 CFR 
351.224(g) following the preliminary determination. Instead, Commerce 
will address such allegations in the final determination together with 
issues raised in the case briefs or other written comments.

Verification

    As provided in section 782(i)(1) of the Act, Commerce intends to 
verify information relied upon in making its final determination.

Public Comment

    Case briefs or other written comments, excluding scope comments, 
may be submitted to the Assistant Secretary for Enforcement and 
Compliance no later than seven days after the date on which the last 
final verification report is issued in this investigation. A timeline 
for the submission of case briefs and written comments will be notified 
to interested parties at a later date. Rebuttal briefs, limited to 
issues raised in the case briefs, may be filed not later than five days 
after the date for filing case briefs.\14\ Interested parties who 
submit case briefs or rebuttal briefs in this proceeding must submit: 
(1) a table of contents listing each issue; and (2) a table of 
authorities.\15\
---------------------------------------------------------------------------

    \14\ See 19 CFR 351.309(d); see also Administrative Protective 
Order, Service, and Other Procedures in Antidumping and 
Countervailing Duty Proceedings, 88 FR 67069, 67077 (September 29, 
2023) (APO and Service Final Rule).
    \15\ See 19 CFR 351.309(c)(2) and (d)(2)
---------------------------------------------------------------------------

    As provided under 19 CFR 351.309(c)(2) and (d)(2), in prior 
proceedings we have encouraged interested parties to provide an 
executive summary of their brief that should be limited to five pages 
total, including footnotes. In this investigation, we instead request 
that interested parties provide at the beginning of their briefs a 
public,

[[Page 22707]]

executive summary for each issue raised in their briefs.\16\ Further, 
we request that interested parties limit their executive summary of 
each issue to no more than 450 words, not including citations. We 
intend to use the executive summaries as the basis of the comment 
summaries included in the issues and decision memorandum that will 
accompany the final determination in this investigation. We request 
that interested parties include footnotes for relevant citations in the 
executive summary of each issue. Note that Commerce has amended certain 
of its requirements pertaining to the service of documents in 19 CFR 
351.303(f).\17\
---------------------------------------------------------------------------

    \16\ We use the term ``issue'' here to describe an argument that 
Commerce would normally address in a comment of the Issues and 
Decision Memorandum.
    \17\ See APO and Service Final Rule.
---------------------------------------------------------------------------

    Pursuant to 19 CFR 351.310(c), interested parties who wish to 
request a hearing, limited to issues raised in the case and rebuttal 
briefs, must submit a written request to the Assistant Secretary for 
Enforcement and Compliance, U.S. Department of Commerce, within 30 days 
after the date of publication of this notice. Requests should contain: 
(1) the party's name, address, and telephone number: (2) the number of 
participants and whether any participant is a foreign national; and (3) 
a list of the issues to be discussed. If a request for a hearing is 
made, Commerce intends to hold the hearing at a time and date to be 
determined. Parties should confirm by telephone the date, time, and 
location of the hearing two days before the scheduled date.

Postponement of Final Determination and Extension of Provisional 
Measures

    Section 735(a)(2) of the Act provides that a final determination 
may be postponed until not later than 135 days after the date of the 
publication of the preliminary determination if, in the event of an 
affirmative preliminary determination, a request for such postponement 
is made by exporters who account for a significant proportion of 
exports of the subject merchandise, or in the event of a negative 
preliminary determination, a request for such postponement is made by 
the petitioners. Pursuant to 19 CFR 351.210(e)(2), Commerce requires 
that requests by respondents for postponement of a final antidumping 
determination be accompanied by a request for extension of provisional 
measures from a four-month period to a period not more than six months 
in duration.
    On May 5 and 6, 2025, pursuant to 19 CFR 351.210(e), Shandong 
Healsee and Shanxi JC, respectively, requested that Commerce postpone 
the final determination and that provisional measures be extended to a 
period not to exceed six months.\18\ On May 9, 2025, Lonza Greenwood 
LLC (the petitioner) also submitted a postponement request.\19\ In 
accordance with section 735(a)(2)(A) of the Act and 19 CFR 
351.210(b)(2)(ii), because: (1) the preliminary determination is 
affirmative; (2) the requesting exporters account for a significant 
proportion of exports of the subject merchandise; and (3) no compelling 
reasons for denial exist, Commerce is postponing the final 
determination and extending the provisional measures from a four-month 
period to a period not greater than six months, Commerce is postponing 
the final determination and extending the provisional measures from a 
four-month period to a period not greater than six months. Accordingly, 
Commerce will make its final determination no later than 135 days after 
the date of publication of this preliminary determination.
---------------------------------------------------------------------------

    \18\ See Shandong Healsee's Letter, ``Request to Postpone Final 
Determination,'' dated May 5, 2025; see also Shanxi JC's Letter, 
``Shanxi JC's Request to Postpone Final Determination,'' dated May 
6, 2025.
    \19\ See Petitioner's Letter, ``Lonza's Request for Postponement 
of {Commerce's{time}  Antidumping Duty Final Determinations,'' dated 
May 9, 2025.
---------------------------------------------------------------------------

U.S. International Trade Commission (ITC) Notification

    In accordance with section 733(f) of the Act, Commerce will notify 
the ITC of its preliminary determination of sales at LTFV. If the final 
determination is affirmative, the ITC will determine before the later 
of 120 days after the date of this preliminary determination or 45 days 
after the final determination whether imports of the subject 
merchandise are materially injuring, or threaten material injury to, 
the U.S. industry.

Notification to Interested Parties

    This determination is issued and published in accordance with 
sections 733(f) and 777(i)(1) of the Act, and 19 CFR 351.205(c).

    Dated: May 22, 2025.
Christopher Abbott,
Deputy Assistant Secretary, for Policy and Negotiations, performing the 
non-exclusive functions and duties of the Assistant Secretary for 
Enforcement and Compliance.

Appendix I

Scope of the Investigation

    The merchandise subject to the scope of this investigation is 
hard empty capsules, which are comprised of two prefabricated, 
hollowed cylindrical sections (cap and body). The cap and body 
pieces each have one closed and rounded end and one open end, and 
are constructed with different or equal diameters at their open 
ends.
    Hard empty capsules are unfilled cylindrical shells composed of 
at least 80 percent by weight of a water soluble polymer that is 
considered non-toxic and appropriate for human or animal consumption 
by the United States Pharmacopeia--National Formulary (USP-NF), Food 
Chemical Codex (FCC), or equivalent standards. The most common 
polymer materials in hard empty capsules are gelatin derived from 
animal collagen (including, but not limited to, pig, cow, or fish 
collagen), hydroxypropyl methylcellulose (HPMC), and pullulan.
    Hard empty capsules may also contain water and additives, such 
as opacifiers, colorants, processing aids, controlled release 
agents, plasticizers, and preservatives. Hard empty capsules may 
also be imprinted or otherwise decorated with markings.
    Hard empty capsules are covered by the scope of this 
investigation regardless of polymer material, additives, 
transparency, opacity, color, imprinting, or other markings.
    Hard empty capsules are also covered by the scope of this 
investigation regardless of their size, weight, length, diameter, 
thickness, and filling capacity.
    Cap and body pieces of hard empty capsules are covered by the 
scope of this investigation regardless of whether they are imported 
together or separately, and regardless of whether they are imported 
in attached or detached form.
    Hard empty capsules covered by the scope of this investigation 
are those that disintegrate in water within 2 hours under tests 
specified in Chapter 701 of the USP-NF, or equivalent disintegration 
tests.
    Hard empty capsules are classifiable under subheadings 
9602.00.1040 and 9602.00.5010 of the Harmonized Tariff Schedule of 
the United States (HTSUS). In addition, hard empty capsules may be 
imported under HTSUS subheading 1905.90.9090; gelatin hard empty 
capsules may be imported under HTSUS subheading 3503.00.5510; HPMC 
hard empty capsules may be imported under HTSUS subheading 
3923.90.0080; and pullulan hard empty capsules may be imported under 
HTSUS subheading 2106.90.9998. Although the HTSUS subheadings are 
provided for convenience and customs purposes, the written 
description of the merchandise covered by this investigation is 
dispositive.

Appendix II

List of Topics Discussed in the Preliminary Decision Memorandum

I. Summary
II. Background
III. Period of Investigation
IV. Discussion of the Methodology
V. Adjustment Under Section 777(A)(f) of the Act
VI. Adjustments to the Cash Deposit Rates for Export Subsidies in 
the Companion Countervailing Duty Investigation
VII. Currency Conversion
VIII. Recommendation

[FR Doc. 2025-09699 Filed 5-28-25; 8:45 am]
BILLING CODE 3510-DS-P